Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge. (2017)

First Author: Opriessnig T
Attributed to:  Host responses underlying immunity funded by BBSRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13567-017-0472-z

PubMed Identifier: 29073936

Publication URI: http://europepmc.org/abstract/MED/29073936

Type: Journal Article/Review

Volume: 48

Parent Publication: Veterinary research

Issue: 1

ISSN: 0928-4249